Viruses, Vol. 16, Pages 627: Trends in and Risk Factors for Drug Resistance in Mycobacterium tuberculosis in HIV-Infected Patients

Viruses, Vol. 16, Pages 627: Trends in and Risk Factors for Drug Resistance in Mycobacterium tuberculosis in HIV-Infected Patients Viruses doi: 10.3390/v16040627 Authors: Xiaoqin Le Xueqin Qian Li Liu Jianjun Sun Wei Song Tangkai Qi Zhenyan Wang Yang Tang Shuibao Xu Junyang Yang Jiangrong Wang Jun Chen Renfang Zhang Zhaoqin Zhu Yinzhong Shen Trends in and risk factors for drug resistance in Mycobacterium tuberculosis (M. tuberculosis) in human immunodeficiency virus (HIV)-infected patients with active tuberculosis were analyzed. The clinical data of M. tuberculosis and HIV-coinfected patients treated at the Shanghai Public Health Clinical Center between 2010 and 2022 were collected. The diagnosis of tuberculosis was confirmed by solid or liquid culture. The phenotypic drug susceptibility test was carried out via the proportional method, and the resistance to first-line and second-line drugs was analyzed. Logistic regression analysis was performed to identify associated risk factors for drug resistance in M. tuberculosis. Of the 304 patients with a M. tuberculosis-positive culture and first-line drug susceptibility test results, 114 (37.5%) were resistant to at least one first-line anti-tuberculosis drug. Of the 93 patients with first-line and second-line drug susceptibility test results, 40 (43%) were resistant to at least one anti-tuberculosis drug, and 20 (21.5%), 27 (29.0%), 19 (20.4%), 16 (17.2%), and 14 (15.1%) were resistant to rifamp...
Source: Viruses - Category: Virology Authors: Tags: Article Source Type: research